Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications

Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review.

Condition: Panniculitis Associated Hemophagocytic Syndrome (HPS)
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Treatment Used: Ruxolitinib
Number of Patients: 2
Published: December 19, 2022

A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?

Condition: Children with Subcutaneous Panniculitis T-Cell Lymphoma (SPTCL)
Journal: Orphanet journal of rare diseases
Treatment Used: Multidrug Combination Chemotherapy vs. Immunomodulatory Therapy
Number of Patients: 18
Published: December 12, 2022

Hemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibition.

Condition: Trisomy 21/Hemophagocytic Lymphohistocytosis (HLH)
Journal: Pediatric rheumatology online journal
Treatment Used: Emapalumab Followed by Baricitinib
Number of Patients: 2
Published: November 19, 2022

Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.

Condition: Secondary Hemophagocytic Lymphohistiocytosis (HLH) in Patients with AIDS
Journal: Frontiers in immunology
Treatment Used: Ruxolitinib
Number of Patients: 2
Published: October 20, 2022

Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.

Condition: Extranodal Nature Killer/T-Cell Lymphoma (ENKTL) with Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Journal: Medicine
Treatment Used: Sintilimab Combined with Chidamide
Number of Patients: 2
Published: October 05, 2022

Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study.

Condition: Secondary Hemophagocytic Lymph histiocytosis (sHLH)
Journal: Orphanet journal of rare diseases
Treatment Used: Tocilizumab
Number of Patients: 64
Published: September 21, 2022

L-DEP regimen is effective as an initial therapy for adult EBV-HLH.

Condition: Epstein-Barr Virus Driven Hemophagocytic Lymphohistiocytosis (EBV-HLH)
Journal: Annals of hematology
Treatment Used: PEG- Asparaginase Combined with Liposomal Doxorubicin, Etoposide, and Methylprednisolone (L-DEP)
Number of Patients: 47
Published: September 12, 2022

Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.

Condition: Hemophagocytic Syndrome with Disseminated Toxoplasmosis in Patient with AIDS
Journal: La Revue de medecine interne
Treatment Used: Etoposide, Anti-Toxoplasmosis Therapy, and Antiretroviral Therapy
Number of Patients: 1
Published: September 11, 2022

Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Condition: Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)
Journal: Annals of hematology
Treatment Used: Methotrexate Combined with Dexamethasone
Number of Patients: 57
Published: September 07, 2022

Disseminated Toxoplasmosis associated with Haemophagocytic Lymphohistiocytosis in a Patient with the Human Immunodeficiency Virus: A Case Report and Literature Review.

Condition: Disseminated Toxoplasmosis associated with Hemophagocytic Lymphohistiocytosis (DT-HLH) in Patient with Human Immunodeficiency Virus (HIV)
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Treatment Used: Sulfamethoxazole-Trimethoprim, Trimethoprim, and Clindamycin
Number of Patients: 1
Published: September 03, 2022

Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis.

Condition: Relapsed/Refractory Pediatric Hemophagocytic Lymphohistiocytosis (HLH)
Journal: Zhonghua yi xue za zhi
Treatment Used: Ruxolitinib Combined with Liposomal Doxorubicin, Etoposide, Methylprednisolone+/-PEG-Asparaginase (RU-DEP+/-L)
Number of Patients: 16
Published: July 25, 2022

Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome.

Condition: Lymphoma-Associated Hemophagocytic Syndrome (LAHS)
Journal: Zhonghua yi xue za zhi
Treatment Used: Anti-Lymphoma Treatment
Number of Patients: 94
Published: July 25, 2022
Showing 1-12 of 146

Last Updated: 02/19/2023